The serum interleukin-6 and tumor necrosis factor-α levels and their relationship with antithrombin-III and von Willebrand factor in preeclampsia

Journal of the Turkish German Gynecology Association

Volumn 7, Issue 1, 2006, Pages 39-44

  Noyan, Tevfik ^a   Bursal, Ercan ^a   Şekeroǧlu, Mehmet Ramazan ^a   Dülger, Haluk ^a   Kamaci, Mansur ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Cytokines; Endothelial dysfunction; Preeclampsia

Indexed keywords

ANTITHROMBIN III; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; PATHOGENESIS; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION;

EID: 33645818178     PISSN: 13090399     EISSN: 13090380     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Department of Health and Social Security. Report on Confidential Enquires into Maternal Deaths. London. 1994;1988-90.
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
3. Hata T, Kawamura T, Fujiwaki R, Aoki S, Hata K, Inada K. Interleukin-4, Interleukin-10 and soluble tumor necrosis factor receptors in cord blood. Gynecol Obstet Invest 1997;43:155-7.
4. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994;14:239-92.
5. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000;47:87-103.
6. Flavahan NA, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995;8:28-41.
7. Paternoster DM, Stella A, Mussap M, Plebani M, Gambro G, Grella PV. Predictive markers of preeclampsia in hypertensive disorders of pregnancy. Int J Gynaecol Obstet 1999;66:237-43.
8. Antovic J, Söderström J, Karlman B, Blomback M. Evaluation of a new immunoturbidimetric test (Liatest antithrombin III) for determination of antithrombin antigen. Clin Lab Haematol 2001;23:313-16.
9. Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost 1992;67:594-9.
10. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:51.
11. Zeeman GG, Dekker GA, van Geijn HP, Kraayenbrink AA. Endothelial function in normal and preeclamptic pregnancy: A hypothesis. Eur J Obstet Gynecol Reprod Biol 1992;43:113-22.
12. Tsunoda T, Ohkuchi A, Izumi A, Watanabe T, Matsubara S, Sato I, Minakami H. Antithrombin III activity and platelet count are more likely to decrease in twin pregnancies than in singleton pregnancies. Acta Obstet Gynecol Scand 2002;81:840-5.
13. Hellgren M, Nygards E-B, Robbe H. Antithrombin III in late pregnancy. Acta Obstet Gynecol Scand 1982;61:187-9.
14. Weiner CP, Brandt J. Plasma antithrombin III activity: An aid in the diagnosis of preeclampsia-eclampsia. Am J Obstet Gynecol 1982;142:275-81.
15. Ho CH, Yang ZL. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost 1992;67:214-8.
16. Paternoster DM, Stella A, Simioni P, Trovo S, Plebani P, Girolami A. Clotting inhibitors and fibronectin as potential markers in preeclampsia. Int J Gynecol Obstet 1994;47:215-21.
17. Paternoster DM, Fantinato S, Manganelli F, Milani M, Nicolini U, Girolami A. Efficacy of AT in preeclampsia: A case-control prospective trial. Thromb Haemost 2004;91:283-9.
18. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989;161:735-41.
19. Ribau JC, Hatton MW, Richardson M. Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats. Atherosclerosis 1998;139:291-9.
20. Mohamed-Ali V, Armstrong L, Clarke D, Bolton CH, Pinkney JH. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes. J Int Med 2001;250:415-21.
21. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, Wennergren M, Hagberg H. Levels of dimetylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001;80:602-8.
22. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20-5.
23. Eneroth E, Remberger M, Vahlne A, Ringden O. Increased serum concentration of interleukin-2 in women who later developed severe preeclampsia. Acta Obstet Gynecol Scand 1998;77:591-3.
24. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R. The relationships between leptin and inflammatory cytokines in women with preeclampsia. BJOG 2001;108:1272-6.
25. Conrad KP, Miles TM, Benyo DE. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40:102-11.
26. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumor necrosis factor-alpha (TNF-α) and the development of preeclampsia. Clin Exp Immunol 1994;98:110-4.
27. Opsjon SL, Austgulen R, Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand 1995;74:19-26.
28. Kupfermine MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996;88:420-7.
29. Galazios G, Papazoglou D, Giagloglou K, Vassaras G, Maltezos E, Anastasiadis P. Interleukin-6 levels in umbilical artery serum in normal and abnormal pregnancies. Int J Gynecol Obstet 2002;78:147-51.
30. Visser W, Beckmann I, Knook MA, Wallenburg HC. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule I as markers of tumor necrosis factor-α release in preeclampsia. Acta Obstet Gynecol Scand 2002;81:713-9.
31. Silver RM, Schwinzer B, McGregor JA. Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: Preeclampsia, small-for-gestational- age-fetus, and premature labor. Am Obstet Gynecol 1993;169:1101-05.
32. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998;179:1359-75.
33. Kharfi A, Giguere Y, Sapin V, Masse J, Dastugue B, Forest JC. Trophoblastic remodeling in normal and preeclamptic pregnancies: Implication of cytokines. Clin Biochem 2003;36:323-31.
34. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001;75:243-9.
35. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP: Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505-12.
36. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-α from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro. A potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004;164:1049-61.
37. Bloxam DL, Bullen BE, Walters BN, Lao TT. Placental glycolysis and energy metabolism in preeclampsia. Am J Obstet Gynecol 1987;157:97-101.